Synlett
DOI: 10.1055/a-2356-8451
letter

Development of a Purely Isolable (Dimorpholino)triazine-based Reagent for the Epoxidation of Alkenes

1   Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan (Ringgold ID: RIN12858)
,
Toshiyuki Kato
1   Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan (Ringgold ID: RIN12858)
,
Tatsuki Betsuyaku
1   Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan (Ringgold ID: RIN12858)
,
2   Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan (Ringgold ID: RIN12881)
1   Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan (Ringgold ID: RIN12858)
› Author Affiliations
Supported by: Japan Society for the Promotion of Science 17H03970

A triazine-based reagent, 2-hydroperoxy-4,6-dimorpholino-1,3,5-triazine (Triazox-II), was developed for alkene epoxidation. This reagent can be prepared from inexpensive starting materials (cyanuric chloride and morpholine) on a 15 mmol scale in two steps with 54% overall yield and isolated as a pure, bench-stable solid with low sensitivity to impact and friction. Triazox-II exhibited higher solubility in chlorinated solvents than the previously reported reagent Triazox. Epoxidation using Triazox-II was conducted in various solvents, with a preference for CH2Cl2 at 0.5 M concentration, resulting in epoxides in 83–94% yield. The reaction was conducted under mild conditions owing to the low acidity of the reaction coproduct.



Publication History

Received: 26 May 2024

Accepted after revision: 27 June 2024

Accepted Manuscript online:
28 June 2024

© . Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany